UN endorses WHO advice on strict controls of dangerous fentanyls
New WHO advice on biosimilar medicines aims to increase access to quality treatment
First in vitro diagnostic prequalified through the alternative performance evaluation mechanism
WHO launches five-year plan to improve the quality and safety of health products
Lymphatic filariasis: 465 million treatments delivered through expanded coverage, combined medicines
Kiribati eliminates lymphatic filariasis
Medical Product Alert N° 3/2019: Falsified ICLUSIG (Asia and globally)
Messages for World Leprosy Day 2020
